1. Home
  2. |Insights
  3. |Back Together Again for OOPS 2022

Back Together Again for OOPS 2022

Event | 05.16.22 - 05.17.22, 3:30 AM EDT - 2:00 PM EDT

Address

Renaissance Washington, DC Downtown Hotel
999 9th Street NW Washington, DC 20001

Register

Government contractors have more to consider today than ever before due to international conflicts, lingering effects of COVID-19 pandemic, supply chain issues, and the ever-changing legal and regulatory landscape. Join us in person for our Annual Ounce of Prevention Seminar (OOPS) where our experienced practitioners will be providing insight in a variety of areas, including national security and globalization/ international trade, infrastructure, bid protests, False Claims Act enforcement, cybersecurity, cost and pricing, and more.  Our program will also feature a conversation with Kerry Hotopp, Assistant General Counsel (Acquisition Integrity), Department of the Navy Suspending and Debarring Official as well as a discussion with Lesley Field, Acting Administrator for Federal Procurement Policy at Office of Management and Budget. Click here to view the OOPS 2022 agenda. 

Following OOPS, we will have a special investigations program “Responding to Government Investigations: The Latest Developments and Strategies for Government Contractors.”  The agenda for this program can be found here.

We look forward to sharing these notable updates and reconnecting with each other in person!

Click here to view the program materials.

This program is intended for government contractors only. Please no private law firms or government employees.

For more information, please visit these areas: Government Contracts, Accounting, Cost, and Pricing

Insights

Event | 02.25.25

Charting a Path for Compliance in Life Sciences

Join us for an interactive and educational event tailored for biotech leaders seeking to ensure security compliance while leveraging the power of Amazon Web Services (AWS). This session will dive into the critical elements of designing secure, scalable, and compliant systems for biotech operations, from research and development to clinical trials and beyond....

View All Insights